Editorial Board and Aims & Scopes
Targeted testing of individuals with a range of signs and symptoms could improve diagnosis of coeliac disease, a new National Institute for Health Research (NIHR) funded study led by the University of Bristol and published in PLOS ONE has found. Signs and symptoms include family history of coeliac disease, dermatitis herpetiformis, anaemia, type 1 diabetes, osteoporosis and chronic liver disease.
Low androgen levels appear to be linked to the development of post-transplantation diabetes mellitus in male kidney transplant recipients, new research suggests.Medscape Medical News
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to...
Condition: Neuropathy Intervention: Device: Erchonia EVRL Sponsor: Erchonia Corporation Recruiting
Condition: Diabetic Foot Ulcer Intervention: Sponsors: University of Michigan; Indiana University; University of Miami; University of California, San Francisco; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford University Recruiting
Conditions: Diabetes; Breast Cancer Interventions: Behavioral: Integrated Intervention for Breast Cancer Survivors with Diabetes; Behavioral: Attention Control Sponsors: Icahn School of Medicine at Mount Sinai; Feinberg School of Medicine, Northwestern University; Feinstein Institute for Medical Research; National Cancer Institute (NCI) Not yet recruiting
Conditions: Type2 Diabetes; NAFLD; Obesity Intervention: Procedure: Bariatric Surgery Sponsors: University of Nottingham; University of Leicester; Medical Research Council; International Stem Cell Forum; University Hospitals of Derby and Burton NHS Foundation Trust Not yet recruiting
Finerenone (Kerendia) has been approved to reduce the risk of sustained estimated glomerular filtration rate decline, end-stage kidney disease, cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.
CONCLUSIONS: Results of our study support the hypothesis that D-allele and DD-genotype of rs35569394 have deleterious effect on the progression of DR. C-allele had skewed frequency towards DR III subjects owing to strong linkage disequilibrium between C-allele (rs699947) and D-allele (rs35569394).PMID:34693874 | DOI:10.1080/13816810.2021.1992786
This study used 2019 National Health Interview Survey data. Persons were included if they were aged less than 50 and had a diabetes diagnosis. Individuals were categorized as nonadherent to medication if they answered "yes" to one question indicating nonadherence. Food security status was categorized as food secure, low food security, and very low food security. Among adults under age 50 with diabetes, nearly a fifth were categorized as having low or very low food security. Approximately a quarter of the participants were not adherent. Respondents with low food security and very low food security were significant...